Authors: DELASZLO SE VISCO D AGARWAL L CHANG L CHIN J CROFT G FORSYTH A FLETCHER D FRANTZ B HACKER C HANLON W HARPER C KOSTURA M LI B LUELL S MACCOSS M MANTLO N ONEILL EA OREVILLO C PANG M PARSONS J ROLANDO A SAHLY Y SIDLER K WIDMER WR OKEEFE SJ

Citation: Se. Delaszlo et al., PYRROLES AND OTHER HETEROCYCLES AS INHIBITORS OF P38 KINASE, Bioorganic & medicinal chemistry letters, 8(19), 1998, pp. 2689-2694

Authors: FLETCHER DS CANDELORE MR GRUJIC D LOWELL BB LUELL S SUSULIC VS MACINTYRE DE

Citation: Ds. Fletcher et al., BETA-3 ADRENERGIC-RECEPTOR AGONISTS CAUSE AN INCREASE IN GASTROINTESTINAL TRANSIT-TIME IN WILD-TYPE MICE, BUT NOT IN MICE LACKING THE BETA-3 ADRENERGIC-RECEPTOR, The Journal of pharmacology and experimental therapeutics, 287(2), 1998, pp. 720-724

Authors: FLETCHER DS WIDMER WR LUELL S CHRISTEN A OREVILLO C SHAH S VISCO D

Citation: Ds. Fletcher et al., THERAPEUTIC ADMINISTRATION OF A SELECTIVE INHIBITOR OF NITRIC-OXIDE SYNTHASE DOES NOT AMELIORATE THE CHRONIC INFLAMMATION AND TISSUE-DAMAGEASSOCIATED WITH ADJUVANT-INDUCED ARTHRITIS IN RATS, The Journal of pharmacology and experimental therapeutics, 284(2), 1998, pp. 714-721

Authors: SWAIN CJ WILLIAMS BJ BAKER R CASCIERI MA CHICCHI G FORREST M HERBERT R KEOWN L LADDUWAHETTY T LUELL S MACINTYRE DE METZGER J MORTON S OWENS AP SADOWSKI S WATT AP

Citation: Cj. Swain et al., 3-BENZYLOXY-2-PHENYLPIPERIDINE NK1 ANTAGONISTS - THE INFLUENCE OF ALPHA-METHYL SUBSTITUTION, Bioorganic & medicinal chemistry letters, 7(23), 1997, pp. 2959-2962

Authors: FLETCHER DS AGARWAL L CHAPMAN KT CHIN J EGGER LA LIMJUCO G LUELL S MACINTYRE DE PETERSON EP THORNBERRY NA KOSTURA MJ

Citation: Ds. Fletcher et al., A SYNTHETIC INHIBITOR OF INTERLEUKIN-1-BETA CONVERTING-ENZYME PREVENTS ENDOTOXIN-INDUCED INTERLEUKIN-1-BETA PRODUCTION IN-VITRO AND IN-VIVO, Journal of interferon & cytokine research, 15(3), 1995, pp. 243-248

Authors: HWANG SB LAM MH SZALKOWSKI DM MACINTYRE DE BACH TJ LUELL S MEUER R SAHOO SP ALBERTS AW CHABALA JC

Citation: Sb. Hwang et al., MK 287 - A POTENT, SPECIFIC, AND ORALLY-ACTIVE RECEPTOR ANTAGONIST OFPLATELET-ACTIVATING-FACTOR, Journal of lipid mediators, 7(2), 1993, pp. 115-134